CACCAMO, GAIA
 Distribuzione geografica
Continente #
NA - Nord America 566
EU - Europa 504
AS - Asia 110
Totale 1.180
Nazione #
US - Stati Uniti d'America 566
IE - Irlanda 202
SE - Svezia 155
CN - Cina 95
IT - Italia 48
UA - Ucraina 27
DE - Germania 24
BE - Belgio 18
FI - Finlandia 15
IN - India 13
GB - Regno Unito 12
FR - Francia 1
IQ - Iraq 1
IR - Iran 1
NO - Norvegia 1
RU - Federazione Russa 1
Totale 1.180
Città #
Dublin 202
Chandler 149
Nyköping 111
Jacksonville 64
Ann Arbor 50
Ashburn 44
Beijing 37
Medford 21
Princeton 21
Messina 19
Brussels 18
Des Moines 15
Cambridge 14
Dearborn 11
Jinan 10
New York 10
Hyderabad 8
Avola 7
Boardman 7
Nanjing 7
Shenyang 6
Catania 5
Pune 5
Zhengzhou 5
Falls Church 4
Guangzhou 4
Nanchang 4
San Mateo 4
Vittoria 4
Wilmington 4
Bremen 3
Chengdu 3
Hebei 3
Nuremberg 3
Woodbridge 3
Haikou 2
Houston 2
Los Angeles 2
Milan 2
Pachino 2
Seattle 2
Alcamo 1
Ardabil 1
Bologna 1
Caserta 1
Changsha 1
Evanston 1
Fuzhou 1
Hangzhou 1
Helsinki 1
Jiaxing 1
Kunming 1
Lanzhou 1
Lappeenranta 1
Monmouth Junction 1
Ningbo 1
Niscemi 1
Norwalk 1
Oslo 1
Philadelphia 1
Puxian 1
Qingdao 1
Saint Paul 1
Saint Petersburg 1
Sortino 1
Taiyuan 1
Taizhou 1
Tappahannock 1
Tianjin 1
Washington 1
Yicheng 1
Totale 927
Nome #
Atrial fibrillation in patients with cirrhosis 95
Hepatitis B virus and hepatitis C virus co-infection: additive players in chronic liver disease? 86
Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases 81
Is there a downgrading in the alert about the hepatitis B virus infection in Italy? 79
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 64
Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection 63
Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C. 60
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. 59
Response to the high diagnostic characteristics of HBsAg level in differentiation of Hepatitis B clinical presentations: myth or truth? 58
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 58
LA NOSTRA ESPERIENZA NELLA RIEDUCAZIONE FUNZIONALE NELLE RIPROTESIZZAZIONI SETTICHE DI GINOCCHIO 54
High prevalence of non-organ-specific autoantibodies in hepatitis C virus-infected cirrhotic patients from southern Italy. 52
Seroprevalence of hepatitis B virus and hepatitis C virus infections in elderly residents in nursing homes in Southern Italy 46
Virological profiles in hepatitis B virus inactive carriers: monthly evaluation in 1-year follow-up study 42
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 42
Erectile dysfunction in compensated liver cirrhosis 39
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 38
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 37
Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study 33
null 31
Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound‑detected liver nodules 30
A combination of different diagnostic tools allows identification of inactive hepatitis B virus carriers at a single time point evaluation 27
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance 24
null 22
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance 3
Totale 1.223
Categoria #
all - tutte 4.708
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.708


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 0 1 1
2019/2020145 21 9 1 8 3 12 20 12 2 37 16 4
2020/2021128 14 1 37 7 11 9 3 21 2 9 9 5
2021/2022171 5 23 1 5 25 3 15 7 1 11 23 52
2022/2023572 36 82 27 44 28 52 20 27 230 2 19 5
2023/2024131 11 21 9 23 13 30 1 5 1 13 4 0
Totale 1.223